Sphere gets CE Mark for second-gen Proxima blood analyzer

12/19/2011 | Reuters

European regulators have granted Sphere Medical CE Mark approval for its Proxima Generation 2 device as an in vitro diagnostic tool. The approval comes after it was reported last month that the device proved to be as effective as point-of-care and laboratory blood gas analyzers in tracking arterial blood in a clinical environment.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Quality Regulatory Affairs
Cardinal Health
Chicago, IL
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC